Strategies Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.74M Buy
4,062
+104
+3% +$105K 0.38% 28
2025
Q4
$4.25M Sell
3,958
-317
-7% -$303K 0.43% 27
2025
Q3
$3.26M Buy
4,275
+404
+10% +$301K 0.34% 28
2025
Q2
$3.02M Buy
3,871
+276
+8% +$214K 0.33% 30
2025
Q1
$2.97M Buy
3,595
+1,049
+41% +$873K 0.36% 30
2024
Q4
$2.22M Buy
+2,546
New +$2.11M 0.28% 34

Other funds holding LLY

Strategies Wealth Advisors's LLY Position: Q1 2026 in Review

Strategies Wealth Advisors increased its Eli Lilly (LLY) stake by 2.6% in Q1 2026, buying an estimated $105K and bringing the position to 4,062 shares worth $3.74M. The position accounts for 0.38% of the portfolio, ranked #28.

Strategies Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.25M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Strategies Wealth Advisors held 4,062 shares of Eli Lilly worth $3.74M as of Q1 2026.
  • Strategies Wealth Advisors bought 104 Eli Lilly shares in Q1 2026, an estimated $105K.
  • Eli Lilly made up 0.38% of Strategies Wealth Advisors's portfolio in Q1 2026, its #28 holding.
  • Strategies Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Strategies Wealth Advisors's Eli Lilly position peaked at $4.25M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Strategies Wealth Advisors's 13F filing for Q1 2026, filed 15 May 2026.